Evoke Pharma Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy EVOK

*Your capital is at risk

$11.00

+0 (+0%)

At Close: Mar 16, 2026

Evoke Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -81.60. In total, the insiders bought 2.96M and sold 1.52M EVOK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-81.60
● Buy	2.96M shares
● Sell	1.52M shares
59% Buy Activity Strong Negative Correlation
Sell Signal High Confidence Dec 17, 2025 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -81.6. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Kowieski Mark Chief Financial Officer	C-Suite Officer	13 000 Value: $57.9K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Carlson Marilyn R. Chief Medical Officer	Officer	11 000 Value: $49.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Carlson Marilyn R. Chief Medical Officer	Officer	11 000 Value: $49.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Kowieski Mark Chief Financial Officer	C-Suite Officer	13 000 Value: $57.9K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Garner Cam L Director	Director	8 750 Value: $38.9K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Brady Todd C Director	Director	5 833 Value: $26.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Hill Malcolm R Director	Director	5 833 Value: $26.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Reed Vickie S Director	Director	5 833 Value: $26.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Widder Kenneth J Director	Director	5 833 Value: $26.0K
Jan 28, 2025 Buy	Stock Option (Right to Buy) A-Award	D'onofrio Matthew J Chief Executive Officer	CEO / President	70 000 Value: $311.5K
Nov 06, 2024 Buy	Common Stock	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	0 Value: $0
Nov 06, 2024 Buy	Common Stock	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	0 Value: $0
Oct 18, 2024 Buy	Stock Option (Right to Buy) A-Award	Smeal Benjamin C. Director	Director	5 833 Value: $32.1K
Oct 18, 2024 Buy	No securities are beneficially owned.	Smeal Benjamin C. Director	Director	0 Value: $0
Oct 18, 2024 Buy	No securities are beneficially owned.	Smeal Benjamin C. Director	Director	0 Value: $0
Sep 27, 2024 Buy	Amended Series A Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	158 682 Value: $2K
Sep 27, 2024 Buy	Amended Series C Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	250 627 Value: $3K
Sep 27, 2024 Buy	Amended Series C Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	250 627 Value: $3K
Sep 27, 2024 Buy	Amended Series A Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	158 682 Value: $2K
Feb 13, 2024 Buy	Pre-Funded Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	433 962 Value: $43
Feb 13, 2024 Buy	Series A Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	117 019 Value: $954.9K
Feb 13, 2024 Buy	Series B Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	245 080 Value: $2.00M
Feb 13, 2024 Buy	Series B Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	245 080 Value: $2.00M
Feb 13, 2024 Buy	Series A Common Stock Purchase Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	117 019 Value: $954.9K
Feb 13, 2024 Buy	Pre-Funded Warrants	Nantahala Capital Management, Llc 10 Percent Owner	10% Owner	433 962 Value: $43

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks